MAP/Microtubule Affinity Regulating Kinase 4 (MARK4)

[Edit]

MARKL1; MAP/Microtubule Affinity Regulating Kinase Like 1

MAP/Microtubule Affinity Regulating Kinase 4 (MARK4)
Sequence analysis predicted that the 752-amino acid MARKL1 protein, 62% identical to MARK3, contains an N-terminal serine/threonine kinase domain, a central ubiquitin-associated domain, and a C-terminal KA1 -associated kinase domain. A smaller transcript, MARKL1S, lacking exon 16 and the KA1-associated kinase domain in the 688-amino acid protein, was also detected exclusively in brain. RT-PCR analysis detected upregulated expression in nearly all clinical hepatocellular carcinoma cells. Northern blot analysis revealed ubiquitous expression of a 3.6-kb transcript, with highest expression in testis. Immunofluorescence microscopy demonstrated homogeneous cytoplasmic expression. Colony-forming assays showed that MARKL1 antisense reduced the growth of SNU475 cells.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) CLIA Kit Customized Service Offer
n/a ELISA Kit for MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) CLIA Kit Customized Service Offer
n/a ELISA Kit for MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) CLIA Kit Customized Service Offer
n/a ELISA Kit for MAP/Microtubule Affinity Regulating Kinase 4 (MARK4) ELISA Kit Customized Service Offer
  1. "Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis."Neoplasia 3:4-9(2001) [PubMed] [Europe PMC] [Abstract]
  2. "Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro."DNA Res. 8:85-95(2001) [PubMed] [Europe PMC] [Abstract]
  3. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  4. "LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1."EMBO J. 23:833-843(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains."Biochem. J. 411:249-260(2008) [PubMed] [Europe PMC] [Abstract]
  6. "Large-scale proteomics analysis of the human kinome."Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract]
  7. "Patterns of somatic mutation in human cancer genomes." Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract]